EPIC | INDV |
Sector | Pharma and Biotech |
ISIN | GB00BN4HT335 |
Market Sector | MAIN |
Market Segment | STMM |
Main Indices | FTSE 250, FTSE 350, FTSE All-Share |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £1,059.03m |
NMS | 7,500 |
Shares in issue | 126.53m |
Date Listed | n/a |
Currency | UK Pounds |
Share Price | 837.00p |
Change Today | 10.50p |
% Change | 1.27 % |
52 Week High | 1,764.00p |
52 Week Low | 576.50p |
Volume | 285,351 |
Shares Issued | 126.53m |
Market Cap | £1,059.03m |
Beta | 1.53 |
RiskGrade | 314 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
16:26 | 0 @ 829.00p |
16:28 | 42 @ 830.50p |
16:28 | 89 @ 830.50p |
16:28 | 211 @ 830.50p |
16:28 | 219 @ 830.50p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research